Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1991 Jun 15;302(6790):1432–1435. doi: 10.1136/bmj.302.6790.1432

Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts.

G L Gilbert 1, S J MacInnes 1, I A Guise 1
PMCID: PMC1670130  PMID: 2070109

Abstract

OBJECTIVE--To determine rates of colonisation with Haemophilus influenzae type b among household contacts of children with invasive H influenzae type b disease; compliance among medical staff with recommendations for use of rifampicin prophylaxis; and effects of rifampicin treatment in H influenzae type b colonisation of patients and contacts. DESIGN--Prospective study of patients and their household contacts. SETTING--Royal Children's Hospital (the major paediatric hospital) in Victoria, Australia, with catchment population of 4.2 million, including 300,000 children aged under 5 years. SUBJECTS--234 patients (age range 6 weeks to 8 years) with 235 episodes of all types of invasive H influenzae type b disease admitted during 1988-9 and their contacts. MAIN OUTCOME MEASURES--Positive cultures of H influenzae type b from throat swabs taken at admission and six weeks subsequently; recording of rifampicin prophylaxis. RESULTS--The percentage of patients with positive throat cultures fell from 69% (33/48) on day 1 of admission to 9% (4/47) after three days' treatment; at six weeks' follow up 32% (32/99) of patients who had not received rifampicin and 8% (5/61) who had, had positive throat cultures. Among household contacts, 33% (62/190) of children and 7% (25/359) of adults were colonised, and the colonisation rates were similar in contacts of patients with all types of H influenzae type b disease. Rifampicin prophylaxis was indicated in 85 families; in 34% it was not prescribed at all for contacts and in 41% not as recommended. The colonisation rates at follow up were significantly less in siblings given rifampicin (12%, 9/78), particularly in families in which all members were treated (3%), than in those in which they were not (36%) (odds ratio 21.5; 95% confidence interval 3.0 to 103.4). CONCLUSIONS--The rate of throat colonisation with H influenzae type b was similar among siblings of children with all types of invasive H influenzae type b disease. Colonisation in contacts can be reduced by rifampicin prophylaxis, but some contacts remained colonised or were recolonised by the time of follow up. Medical staff complied poorly with current recommendations for rifampicin prophylaxis, which reduces its intrinsically limited value in preventing H influenzae type b disease.

Full text

PDF
1432

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpert G., Campos J. M., Smith D. R., Barenkamp S. J., Fleisher G. R. Incidence and persistence of Haemophilus influenzae type b upper airway colonization in patients with meningitis. J Pediatr. 1985 Oct;107(4):555–557. doi: 10.1016/s0022-3476(85)80018-4. [DOI] [PubMed] [Google Scholar]
  2. Band J. D., Fraser D. W., Ajello G. Prevention of Hemophilus influenzae type b disease. JAMA. 1984 May 11;251(18):2381–2386. [PubMed] [Google Scholar]
  3. Boies E. G., Granoff D. M., Squires J. E., Barenkamp S. J. Development of Haemophilus influenzae type b meningitis in a household contact treated with rifampin. Pediatrics. 1982 Jul;70(1):141–142. [PubMed] [Google Scholar]
  4. Campbell L. R., Zedd A. J., Michaels R. H. Household spread of infection due to Haemophilus influenzae type b. Pediatrics. 1980 Jul;66(1):115–117. [PubMed] [Google Scholar]
  5. Clements D. A., Gilbert G. L. Immunisation for the prevention of Haemophilus influenzae type b infections: a review. Aust N Z J Med. 1990 Dec;20(6):828–834. doi: 10.1111/j.1445-5994.1990.tb00435.x. [DOI] [PubMed] [Google Scholar]
  6. Daum R. S., Glode M. P., Goldmann D. A., Halsey N., Ambrosino D., Welborn C., Mather F. J., Willard J. E., Sullivan B., Murray M. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b. J Pediatr. 1981 Mar;98(3):485–491. doi: 10.1016/s0022-3476(81)80731-7. [DOI] [PubMed] [Google Scholar]
  7. Gilbert G. L., Clements D. A., Broughton S. J. Haemophilus influenzae type b infections in Victoria, Australia, 1985 to 1987. Pediatr Infect Dis J. 1990 Apr;9(4):252–257. doi: 10.1097/00006454-199004000-00006. [DOI] [PubMed] [Google Scholar]
  8. Gilbert G. L. Epidemiology and prevention of invasive Haemophilus influenzae type b infection. Aust Paediatr J. 1987 Dec;23(6):323–327. doi: 10.1111/j.1440-1754.1987.tb00283.x. [DOI] [PubMed] [Google Scholar]
  9. Gilsdorf J. R. Dynamics of nasopharyngeal colonization with Haemophilus influenzae b during antibiotic therapy. Pediatrics. 1986 Feb;77(2):242–245. [PubMed] [Google Scholar]
  10. Glode M. P., Daum R. S., Boies E. G., Ballard T. L., Murray M., Granoff D. M. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts. Pediatrics. 1985 Oct;76(4):537–542. [PubMed] [Google Scholar]
  11. Glode M. P., Daum R. S., Goldmann D. A., Leclair J., Smith A. Haemophilus influenzae type B meningitis: a contagious disease of children. Br Med J. 1980 Mar 29;280(6218):899–901. doi: 10.1136/bmj.280.6218.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Li K. I., Wald E. R. Use of rifampin in Haemophilus influenzae type b infections. Am J Dis Child. 1986 Apr;140(4):381–385. doi: 10.1001/archpedi.1986.02140180115040. [DOI] [PubMed] [Google Scholar]
  13. Michaels R. H., Poziviak C. S., Stonebraker F. E., Norden C. W. Factors affecting pharyngeal Haemophilus influenzae type b colonization rates in children. J Clin Microbiol. 1976 Nov;4(5):413–417. doi: 10.1128/jcm.4.5.413-417.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Michaels R. H., Stonebraker F. E., Robbins J. B. Use of antiserum agar for detection of Haemophilus influenzae type b in the pharynx. Pediatr Res. 1975 May;9(5):513–516. doi: 10.1203/00006450-197505000-00010. [DOI] [PubMed] [Google Scholar]
  15. Murphy T. V., McCracken G. H., Jr, Zweighaft T. C., Hansen E. J. Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis. J Pediatr. 1981 Sep;99(3):406–409. doi: 10.1016/s0022-3476(81)80328-9. [DOI] [PubMed] [Google Scholar]
  16. Schwartz B., Al-Tobaiqi A., Al-Ruwais A., Fontaine R. E., A'ashi J., Hightower A. W., Broome C. V., Music S. I. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet. 1988 Jun 4;1(8597):1239–1242. doi: 10.1016/s0140-6736(88)92069-7. [DOI] [PubMed] [Google Scholar]
  17. Shapiro E. D., Wald E. R. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b. Pediatrics. 1980 Jul;66(1):5–8. [PubMed] [Google Scholar]
  18. Thirumoorthi M. C., Dajani A. S. Yersinia enterocolitica osteomyelitis in a child. Am J Dis Child. 1978 Jun;132(6):578–580. doi: 10.1001/archpedi.1978.02120310042007. [DOI] [PubMed] [Google Scholar]
  19. Ward J. I., Fraser D. W., Baraff L. J., Plikaytis B. D. Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. N Engl J Med. 1979 Jul 19;301(3):122–126. doi: 10.1056/NEJM197907193010302. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES